Crestline Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-61,950	Closed	-$610K	–	261
2022 Q2	$610K	Hold	61,950	–	–	0.08%	152
2022 Q1	$607K	Buy	61,950 +8,100	+15%	+$79.4K	0.07%	157
2021 Q4	$532K	Hold	53,850	–	–	0.04%	152
2021 Q3	$535K	Buy	+53,850	New	+$535K	0.05%	142